CPT code 92972 designates percutaneous coronary lithotripsy performed as an add-on to another coronary intervention to fracture vascular calcifications. As an adjunct to percutaneous coronary procedures, intravascular lithotripsy facilitates lesion preparation and device delivery in heavily calcified coronary arteries, which can affect procedural success and downstream patient outcomes. The code matters nationally as use of specialized coronary plaque modification tools grows alongside an aging population with complex coronary disease.

Key payers covered in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for intravascular coronary lithotripsy, discussion of typical sites of service (hospital catheterization laboratories and outpatient cath suites), and what to expect in billing practice when 92972 is billed as an add-on to primary coronary procedures. The publication also highlights benchmarks and policy-relevant considerations for coverage and coding alignment across major payers, and summarizes implications for procedural workflow and documentation. Data not available in the input where payer-specific rates, taxonomies, ICD-10 pairings, and related code lists would normally appear.